This Pharma Stock Jumps Over 8% As Volume Hits Highest Level In More Than Two Weeks

Indian equity benchmarks traded higher on Thursday, with the benchmark Nifty 50 index gaining 65.05 points, or 0.28 per cent, to 23,280.00. Amid the positive market sentiment, Blue Jet Healthcare share price surged 8.54 per cent to Rs 509.85, supported by strong trading volumes of approximately 49.6 lakh shares, significantly above the average volume of 10.3 lakh shares. Notably, this was also higher than the 41.7 lakh shares traded on May 26, 2026, marking the stock's highest trading volume in more than two weeks.

Blue Jet Healthcare ROE Consistent Performance

Blue Jet Healthcare has maintained a healthy profitability profile, reporting a three-year Return on Equity (ROE) of 24 per cent. The strong return ratio results in the company's ability to generate earnings efficiently from shareholders' capital while maintaining operational discipline.

Blue Jet Healthcare Stock Performance

The stock has delivered positive returns across multiple timeframes. Shares have gained 7.39 per cent during the last month and 8.01 per cent over the past six months.

On a longer-term basis, the stock has generated 46.89 per cent returns over the past year, highlighting strong investor interest in the company's growth prospects.
Also Read - From Rs 38 To Over Rs 18,800: This Multibagger Defence Stock Guides For Rs 14,000 Crore FY27 Revenue; Check Key Details

Market Capitalisation Near Rs 8,770 Crore

Blue Jet Healthcare currently commands a market capitalisation of approximately Rs 8,770 crore, placing it among the notable Mid-Cap companies in India's pharmaceutical and healthcare manufacturing space.

About Blue Jet Healthcare

Blue Jet Healthcare Ltd is a specialty pharmaceutical and healthcare ingredients company engaged in the manufacturing of high-value pharmaceutical intermediates and active ingredients. The company primarily serves global pharmaceutical, healthcare and specialty chemical markets.

The company has developed expertise in niche chemistry segments and focuses on products used in contrast media intermediates, pharmaceutical ingredients and other specialty healthcare applications. Its customer base spans regulated and international markets, enabling it to benefit from increasing global demand for specialised healthcare products.

What are your thoughts on Blue Jet Healthcare's growth prospects and recent stock performance? Share your views in the comments below.
Disclaimer: The article is for informational purposes only and not investment advice.